StockData
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. (TPST) stock

TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.33−0.01 (-4.24%)

Close on Nov 17, 2026Market cap $4.85MP/E –Yield –

Tempest Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Tempest Therapeutics's profit margin for the twelve months ending Sep 30, 2018 was -19991.2%. For fiscal 2017 it was -28670.5%, against -12597.2% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2017Dec 31, 2017-28670.5%−16073.3
FY2016Dec 31, 2016-12597.2%+13835.6
FY2015Dec 31, 2015-26432.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2018Sep 30, 2018-13701.8%+3025.0
Q2 FY2018Jun 30, 2018-5982.7%+15667.3
Q1 FY2018Mar 31, 2018-6359.7%+17283.2
Q4 FY2017Dec 31, 2017-46297.8%−27584.6
Q3 FY2017Sep 30, 2017-16726.8%−6934.4
Q2 FY2017Jun 30, 2017-21650.0%–
Q1 FY2017Mar 31, 2017-23642.9%–
Q4 FY2016Dec 31, 2016-18713.2%–
Q3 FY2016Sep 30, 2016-9792.4%–

More Tempest Therapeutics figures

See a number that looks wrong?